(Press-News.org) (BOSTON) - Last year, a Wyss Institute team of scientists described the development of a new device to treat sepsis that works by mimicking our spleen. It cleanses pathogens and toxins from blood circulating through a dialysis-like circuit. Now, the Wyss Institute team has developed an improved device that synergizes with conventional antibiotic therapies and that has been streamlined to better position it for near-term translation to the clinic. The improved design is described in the October volume 67 of Biomaterials.
Sepsis is a common and frequently fatal medical complication that can occur when a person's body attempts to fight off serious infection. Resulting widespread inflammation can cause organs to shut down, blood pressure to drop, and the heart to weaken. This can lead to septic shock, and more than 30 percent of septic patients in the United States eventually die. In most cases, the pathogen responsible for triggering the septic condition is never pinpointed, so clinicians blindly prescribe an antibiotic course in a blanket attempt to stave off infectious bacteria and halt the body's dangerous inflammatory response.
But sepsis can be caused by a wide-ranging variety of pathogens that are not susceptible to antibiotics, including viruses, fungi and parasites. What's more, even when antibiotics are effective at killing invading bacteria, the dead pathogens fragment and release toxins into the patient's bloodstream.
"The inflammatory cascade that leads to sepsis is triggered by pathogens, and specifically by the toxins they release," said Wyss Institute Founding Director Donald Ingber, M.D., Ph.D., who leads the Wyss team developing the device and is the Judah Folkman Professor of Vascular Biology at Boston Children's Hospital and Harvard Medical School and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Science. "Thus, the most effective strategy is to treat with the best antibiotics you can muster, while also removing the toxins and remaining pathogens from the patient's blood as quickly as possible."
The Wyss team's blood-cleansing approach can be administered quickly, even without identifying the infectious agent. This is because it uses the Wyss Institute's proprietary pathogen-capturing agent, FcMBL, that binds all types of live and dead infectious microbes, including bacteria, fungi, viruses, as well as toxins they release. FcMBL is a genetically engineered blood protein inspired by a naturally-occurring human molecule called Mannose Binding Lectin (MBL), which is found in the innate immune system and binds to toxic invaders, marking them for capture by immune cells in the spleen.
The original device concept was similar to how a dialysis machine works: infected blood in an animal, or potentially one day in a patient, is flowed from one vein through catheters to the device where FcMBL-coated magnetic beads are added to the blood, and then the bead-bound pathogens are extracted from the circulating blood by magnets within the device before the cleansed blood is returned to the body through another vein.
The new and improved device removes the complexity, regulatory challenges and cost associated with the magnetic beads and microfluidic architecture of its predecessor, but it retains the ability of the FcMBL protein to bind to all different kinds of live or dead pathogens and toxins. The optimized system uses hollow fiber filters found in already-FDA-approved dialysis cartridges whose inner walls are coated with FcMBL protein to remove pathogens from circulating blood. In animal studies, treatment with this new pathogen-extracting device reduced the number of E. coli, Staphylococcus aureus and endotoxins circulating in the bloodstream by more than 99 percent.
"Using the device, alone or alongside antibiotics, we can quickly bring blood back to normal conditions, curtailing an inflammatory response rather than exacerbating it," said the paper's first author Tohid Fatanat Didar, Ph.D., Postdoctoral Fellow at the Wyss Institute and Research Fellow at Boston Children's Hospital. "If all goes well, physicians will someday be able to use the device in tandem with standard antibiotic treatments to deliver a one-two punch to pathogens, synergistically killing and cleansing all live and dead invaders from the bloodstream."
With the new improved blood-cleansing therapeutic device proving extremely effective in small animal studies, the Wyss team is planning to move to large animal studies as a next step to demonstrate the proof-of-concept that is required before it could advance to human clinical trials.
"Seeing our system work in animal models gives us confidence that this could work in humans, because we are successfully treating animals infected with human pathogens," said Wyss Senior Staff Scientist Michael Super, Ph.D., who works on the Institute's Advanced Technology Team and is also an author on the new study.
"Since the development of earlier prototypes of the device, we've applied the Wyss model of de-risking the technology to prime it for commercialization," said Ingber. "Our goal is to see this move out of the lab and into hospitals as well as onto the battlefield, where it can save lives within years rather than decades."
INFORMATION:
This work was supported by the Defense Advanced Research Projects Agency and the Wyss Institute for Biologically Inspired Engineering at Harvard University.
IMAGE AND ANIMATION AVAILABLE
The Wyss Institute for Biologically Inspired Engineering at Harvard University uses Nature's design principles to develop bioinspired materials and devices that will transform medicine and create a more sustainable world. Wyss researchers are developing innovative new engineering solutions for healthcare, energy, architecture, robotics, and manufacturing that are translated into commercial products and therapies through collaborations with clinical investigators, corporate alliances, and formation of new start-ups. The Wyss Institute creates transformative technological breakthroughs by engaging in high risk research, and crosses disciplinary and institutional barriers, working as an alliance that includes Harvard's Schools of Medicine, Engineering, Arts & Sciences and Design, and in partnership with Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, the University of Massachusetts Medical School, Spaulding Rehabilitation Hospital, Boston University, Tufts University, and Charité - Universitätsmedizin Berlin, University of Zurich and Massachusetts Institute of Technology.
Having a baby at home can save thousands of dollars over a hospital birth and is just as safe for low-risk births, according to a new UBC study.
Researchers with UBC's School of Population and Public Health and the Child and Family Research Institute looked at all planned home births attended by registered midwives in B.C. between 2001 and 2004. They compared them to planned hospital births attended by registered midwives or physicians in which the mothers met the criteria for home birth.
For the first 28 days postpartum, they found planned home births saved an average ...
Amsterdam, August 20, 2015 - A new study published in Journal of Transport & Health reveals that middle-aged drivers are at higher risk of crashes because they use their cellphone regularly while driving. The research reveals that most drivers admit to using their cellphones regularly while driving, even with children in the car; drivers also feel pressured to answer work calls while driving.
The authors of the study, from the University of California San Diego, are now working with companies to teach employees about the risks associated with distracted driving, and show ...
TORONTO, Aug. 20, 2015--A new study has found a "significant association" between adults who have suffered a traumatic brain injury at some point in their lives and who also have attention deficit hyperactive disorder.
The study, published today in the Journal of Psychiatric Research, supports research that found a similar association in children, said Dr. Gabriela Ilie, lead author of the study and a post-doctoral fellow at St. Michael's Hospital.
The data used in the adult study was collected by the Centre for Addiction and Mental Health's Monitor, a continuous, cross-sectional ...
Oxford, August 20, 2015 - Researchers in China have developed tiny nanocrystals that could be used in the next generation of medical imaging technologies to light up cancer cells. In a study published in the inaugural issue of the journal Applied Materials Today, a new rapid, online only publication, the team of researchers describe how they make these films which are based on the heavy metals lanthanum and europium.
Dr. Yaping Du of Xi'an Jiaotong University, China, and colleagues have developed a way to make high-quality nanocrystals of lanthanide oxybromides, where ...
NEW YORK, NY - Patients with scoliosis who undergo surgery may be less likely to develop an infection or other complications after the procedure when a novel wound closure technique pioneered at NYU Langone Medical Center is utilized, according to new research. The study was published online this past July in the Journal of Pediatric Orthopaedics.
In this new technique, surgeons use a multilayered flap closure that enables doctors to close several layers of muscle and fascia while maintaining blood supply from the donor site to the recipient site. The researchers believe ...
Post-discharge disease management provided in their own homes could be a cost-effective alternative for recently-hospitalised elderly patients with chronic heart failure (CHF).
Just published in the International Journal of Cardiology, this is the finding of a recent economic evaluation conducted by Griffith University using data from a randomised controlled trial (The WHICH Study).
In collaboration with the Australian Catholic University, 280 patients with CHF recruited from three public hospitals, received multidisciplinary disease management.
With the aim of reducing ...
The solid waste left over from wine-making could make a competitive biofuel, University of Adelaide researchers have found.
Published in the journal Bioresource Technology, the researchers showed that up to 400 litres of bioethanol could be produced by fermentation of a tonne of grape marc (the leftover skins, stalks and seeds from wine-making).
Global wine production leaves an estimated 13 million tonnes of grape marc waste each year. Nationally it is estimated that several hundred thousand tonnes are generated annually and it is generally disposed of at a cost to ...
The problem has been that the vast majority of these atomically thin 2D crystals are unstable in air, so react and decompose before their properties can be determined and their potential applications investigated.
Writing in Nano Letters, the University of Manchester team demonstrate how tailored fabrication methods can make these previously inaccessible materials useful.
By protecting the new reactive crystals with more stable 2D materials, such as graphene, via computer control in a specially designed inert gas chamber environments, these materials can be successfully ...
In the Arctic, warming increases like a spiral. Global warming means that the periods of growth are becoming longer and vegetation growth is increasing. At the same time, heat transfer to the Arctic from lower latitudes is rising, reducing sea ice there, and this in turn is contributing towards a faster local rise in temperature.
A new research study published in the highly respected research journal PNAS shows that the situation is the reverse on the Tibetan Plateau.
Vegetation on the Tibetan Plateau has also increased as a result of global warming. However, in contrast ...
A team at the University of Warsaw, Faculty of Physics has created a laser capable of generating ultrashort pulses of light even under extremely difficult external conditions. This unique combination of precision and resilience is due to the fact that the whole process of generating femtosecond laser pulses takes place within a specially-selected optical fiber.
Its appearance seems quite inconspicuous: just a flat, rectangular box, tens of centimeters across and about the same height, with a thin, shiny-tipped "thread" leading out of it, so long that it is rolled up ...
